AR010304A1 - Compuestos de dimesilato de cis-1-(3-etoxifenil)-1-4-fenilpiperazin-1-il) -4-metilciclohexano; procedimiento para su preparacion y composicionfarmaceutica - Google Patents

Compuestos de dimesilato de cis-1-(3-etoxifenil)-1-4-fenilpiperazin-1-il) -4-metilciclohexano; procedimiento para su preparacion y composicionfarmaceutica

Info

Publication number
AR010304A1
AR010304A1 ARP970105494A ARP970105494A AR010304A1 AR 010304 A1 AR010304 A1 AR 010304A1 AR P970105494 A ARP970105494 A AR P970105494A AR P970105494 A ARP970105494 A AR P970105494A AR 010304 A1 AR010304 A1 AR 010304A1
Authority
AR
Argentina
Prior art keywords
phenylpiperazin
ethoxyphenyl
cis
dimesylate
methylciclohexane
Prior art date
Application number
ARP970105494A
Other languages
English (en)
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of AR010304A1 publication Critical patent/AR010304A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/08—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
    • C07D295/096—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Obesity (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

La sal dimesilato del cis-1-(3-etoxifenil)-1-(4-fenilpiperazin-1-il)-4- metilciclohexano tienen propiedades excelentes y es util para el tratamiento detrastoronos fisiologicos asociados con un exceso de neuropéptido Y. Método para preparar dichocompuesto que incluye suspension en un solvente, calentamiento yaislacion.
ARP970105494A 1996-11-26 1997-11-24 Compuestos de dimesilato de cis-1-(3-etoxifenil)-1-4-fenilpiperazin-1-il) -4-metilciclohexano; procedimiento para su preparacion y composicionfarmaceutica AR010304A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US3181596P 1996-11-26 1996-11-26

Publications (1)

Publication Number Publication Date
AR010304A1 true AR010304A1 (es) 2000-06-07

Family

ID=21861551

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP970105494A AR010304A1 (es) 1996-11-26 1997-11-24 Compuestos de dimesilato de cis-1-(3-etoxifenil)-1-4-fenilpiperazin-1-il) -4-metilciclohexano; procedimiento para su preparacion y composicionfarmaceutica

Country Status (23)

Country Link
US (1) US5914329A (es)
EP (1) EP0944611B1 (es)
JP (1) JP3120861B2 (es)
AP (1) AP9701148A0 (es)
AR (1) AR010304A1 (es)
AT (1) ATE257472T1 (es)
AU (1) AU4792497A (es)
BR (1) BR9713538A (es)
CA (1) CA2272927C (es)
DE (1) DE69727155T2 (es)
DK (1) DK0944611T3 (es)
ES (1) ES2213207T3 (es)
GT (1) GT199700123A (es)
HN (1) HN1997000154A (es)
HR (1) HRP970640A2 (es)
ID (1) ID18964A (es)
MA (1) MA26450A1 (es)
PA (1) PA8441701A1 (es)
PE (1) PE17099A1 (es)
PT (1) PT944611E (es)
TN (1) TNSN97191A1 (es)
WO (1) WO1998023603A1 (es)
ZA (1) ZA9710587B (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001053477A1 (en) * 2000-01-20 2001-07-26 Baylor College Of Medicine Methods and compositions for control of bone formation via modulation of neuropeptide y activity
CN1630514A (zh) 2001-12-05 2005-06-22 贝勒医学院 通过调节交感神经紧张性控制骨形成的方法和组合物
NZ533848A (en) 2002-01-09 2006-11-30 Arexis Ab Detection of mutations in the flavin-containing monooxygenase (FMO3) gene
WO2006057507A1 (en) * 2004-11-23 2006-06-01 Dong Wha Pharm.Ind.Co., Ltd An oral preparation having improved bioavailability
EP1877076A4 (en) * 2005-04-15 2012-02-01 Regenertech Pty Ltd USE OF NEUROPEPTIDES Y (NPY) AND AGONIST OF ANTAGONISTS THEREOF FOR REGENERATING TISSUES

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR9509610A (pt) * 1994-11-07 1997-10-28 Pfizer Ligandos específicos de neuropeptideo Y1

Also Published As

Publication number Publication date
ZA9710587B (en) 1999-05-25
ID18964A (id) 1998-05-28
US5914329A (en) 1999-06-22
AP9701148A0 (en) 1998-01-31
EP0944611B1 (en) 2004-01-07
MA26450A1 (fr) 2004-12-20
AU4792497A (en) 1998-06-22
JP2000505110A (ja) 2000-04-25
CA2272927A1 (en) 1998-06-04
DE69727155D1 (de) 2004-02-12
JP3120861B2 (ja) 2000-12-25
DK0944611T3 (da) 2004-04-13
HN1997000154A (es) 1999-02-09
PA8441701A1 (es) 2000-05-24
EP0944611A1 (en) 1999-09-29
GT199700123A (es) 1999-05-19
WO1998023603A1 (en) 1998-06-04
PT944611E (pt) 2004-04-30
TNSN97191A1 (fr) 2005-03-15
DE69727155T2 (de) 2004-07-08
ATE257472T1 (de) 2004-01-15
HRP970640A2 (en) 1998-10-31
CA2272927C (en) 2003-02-04
PE17099A1 (es) 1999-02-19
ES2213207T3 (es) 2004-08-16
BR9713538A (es) 2000-03-21

Similar Documents

Publication Publication Date Title
BR9506305A (pt) Aparelho e processo para preparação de formas sólidas com desprendimento controlado do ingrediente ativo
PT918774E (pt) Compostos moduladores do receptor para androgenio e metodos
PT800519E (pt) Compostos moduladores de receptores de esteroides e metodos
ATE234092T1 (de) 2-alkylpyrrolidine
PT804196E (pt) Utilizacao de antagonistas de serotonina (5ht3) para o tratamento de fibromialgia
EA199800667A1 (ru) Новые фенантридины
ATE211743T1 (de) Substituierte 3-aminochinuclidine
ES2196072T3 (es) Empleo de compuestos heterociclicos como ligandos de dopamina-d3.
BR0206985A (pt) Anticorpos modificados e métodos de uso
RS51123B (sr) Aril fuzionisana azapoliciklična jedinjenja
SE8503680L (sv) Indolderivat
UY26130A1 (es) Compuestos para tratar la obesidad
KR950002785A (ko) 골량을 증가시키기 위한 부갑상선 호르몬 및 랄옥시펜
ATE256671T1 (de) 2-phenyl-substituierte 1-(n-phenylaminoalkyl)- piperazin-derivate
BR0015416A (pt) Composições contendo derivados do ácido hidroxieicosa tetraenóico e métodos de uso no tratamento de distúrbios de olhos secos
ES525737A0 (es) Un procedimiento para la preparacion de nuevas idolonas.
ATE163290T1 (de) Imidazol-verbindungen, verfahren zu ihrer herstellung und ihre anwendung
MX6192E (es) Procedimiento para la preparacion de benzamidas heterociclicas substituidas
AR010304A1 (es) Compuestos de dimesilato de cis-1-(3-etoxifenil)-1-4-fenilpiperazin-1-il) -4-metilciclohexano; procedimiento para su preparacion y composicionfarmaceutica
PT99435A (pt) Processo para a preparacao de derivados de amino-sulfonil-ureia e de composicoes farmaceuticas que os contem
EP1254260A4 (en) METHODS FOR DIAGNOSING AND TREATING A HEART DISEASE
ES2103825T3 (es) Composiciones farmaceuticas que contienen 5-difluorometoxi-2-(3,4-dimetoxi-2-piridil)-metilsulfinil)bencimidazol y un agente anti-helicobacter para el tratamiento de trastornos gastrointestinales.
ES2134184T3 (es) Empleo de etisterona para el tratamiento topico del acne o de la alopecia androgenetica.
EA199800864A1 (ru) Способ лечения при боли, вызванной мигренью
DE69526584T2 (de) Verwendung von immunosuppressiva zur behandlung der schizophrenie